T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Surrozen
SRZN
$347M
| $721K | ﹤0.01% |
27,741
+6,026
| +28% | +$166K |
|
2452
Corsair Gaming
CRSR
$1.48B
| $720K | ﹤0.01% |
74,389
+13,770
| +23% | +$107K |
|
2453
Genesco
GCO
$374M
| $718K | ﹤0.01% |
21,258
+2,899
| +16% | +$102K |
|
|
BIOA
2454
BioAge Labs
BIOA
$324M
| $717K | ﹤0.01% |
29,247
+7,829
| +37% | +$141K |
|
2455
Phathom Pharmaceuticals
PHAT
$591M
| $714K | ﹤0.01% |
65,722
+13,269
| +25% | +$151K |
|
2456
Transcat
TRNS
$821M
| $714K | ﹤0.01% |
7,695
+1,018
| +15% | +$83.1K |
|
2457
Esquire Financial Holdings
ESQ
$1.48B
| $713K | ﹤0.01% |
5,981
+789
| +15% | +$87.4K |
|
2458
Farmers National Banc Corp
FMNB
$914M
| $713K | ﹤0.01% |
48,812
+7,972
| +20% | +$112K |
|
2459
Quanex
NX
$905M
| $712K | ﹤0.01% |
38,227
+3,316
| +9% | +$61.2K |
|
|
ONT
2460
Onterris Inc
ONT
$492M
| $709K | ﹤0.01% |
35,047
+4,320
| +14% | +$80.6K |
|
2461
Fulgent Genetics
FLGT
$611M
| $706K | ﹤0.01% |
34,380
+7,706
| +29% | +$131K |
|
|
NUTX
2462
Nutex Health
NUTX
$1.51B
| $705K | ﹤0.01% |
4,120
+472
| +13% | +$59.8K |
|
|
TBCH
2463
Turtle Beach Corp
TBCH
$228M
| $705K | ﹤0.01% |
56,585
+4,805
| +9% | +$56.9K |
|
2464
Equity Bancshares
EQBK
$996M
| $700K | ﹤0.01% |
14,279
+2,368
| +20% | +$109K |
|
2465
Burford Capital
BUR
$799M
| $698K | ﹤0.01% |
170,187
+24,383
| +17% | +$111K |
|
2466
Zevra Therapeutics
ZVRA
$656M
| $694K | ﹤0.01% |
48,379
+4,763
| +11% | +$52.9K |
|
2467
iHeartMedia
IHRT
$354M
| $690K | ﹤0.01% |
160,647
+27,426
| +21% | +$122K |
|
2468
MetroCity Bankshares
MCBS
$1.01B
| $690K | ﹤0.01% |
19,210
+3,911
| +26% | +$127K |
|
2469
Park-Ohio Holdings
PKOH
$696M
| $687K | ﹤0.01% |
17,843
+1,102
| +7% | +$33.9K |
|
|
ALOY
2470
REalloys Inc
ALOY
$618M
| $685K | ﹤0.01% |
+47,373
| New | +$540K |
|
2471
Opko Health
OPK
$1.22B
| $684K | ﹤0.01% |
455,748
+51,096
| +13% | +$65.2K |
|
2472
Ethan Allen Interiors
ETD
$537M
| $681K | ﹤0.01% |
30,450
+3,017
| +11% | +$64K |
|
2473
Target Hospitality
TH
$2.02B
| $681K | ﹤0.01% |
33,407
+12,353
| +59% | +$206K |
|
|
BBNX
2474
Beta Bionics
BBNX
$1.16B
| $681K | ﹤0.01% |
43,450
+7,978
| +22% | +$94.9K |
|
2475
Daily Journal
DJCO
$905M
| $677K | ﹤0.01% |
1,126
+160
| +17% | +$83.2K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.